Global Hormonal Implants Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In 30th March 2024, it was reported that Canada will cover the full cost of contraception for women as announced by the government and highlighted the first part of a major health care reform.

• In May 2016, ALLERGAN took an initiative to help the US military servicewomen access LILETTA at a Federal Supply Schedule (FSS) price of USD 55.83 to military treatment facilities nationwide. The initiative also includes an educational effort to raise contraception awareness among healthcare providers treating the US military servicewomen.

The Global Hormonal Implants Market is witnessing significant growth due to the increasing demand for long-term, effective, and reversible contraceptive methods. The market has been segmented by hormone into Levonorgestrel and Etonogestrel, with Levonorgestrel-based implants being particularly popular due to their proven efficacy and long-lasting results, offering protection against pregnancy for up to five years. Etonogestrel-based implants are also widely used and have a similar duration of effectiveness, with both hormones offering reliable contraception while presenting fewer side effects compared to oral contraceptives. The choice between Levonorgestrel and Etonogestrel is often based on the patient's medical history and personal preferences, as both are highly effective in preventing pregnancy but may vary in side effects and specific use cases.

When it comes to type, the hormonal implant devices are typically available in two main forms: One Rod Device and Two Rod Device. One Rod Devices are more common and are simpler to insert, offering a more discrete option with minimal discomfort. These implants generally last for three years, providing an extended period of contraceptive protection. On the other hand, Two Rod Devices tend to have a longer lifespan and may provide more consistent release of hormones. While both devices offer effective contraception, the choice between one rod and two rod implants depends on factors such as patient preference, cost, and the desired duration of effectiveness.

In terms of distribution sector, the market is divided into the Public Sector and Private Sector. The public sector plays a significant role in providing affordable and accessible hormonal implants, especially in developing countries where government health programs and non-governmental organizations distribute these products at subsidized rates. The private sector, however, offers a more tailored experience, with patients often opting for hormonal implants through private healthcare providers that provide personalized care and faster access to treatments, although at a higher cost.

The end-user segment includes Hospitals & Clinics and Academic & Research Institutes. Hospitals and clinics are the primary settings for the implantation procedure, with trained medical professionals offering these services to women seeking long-term contraceptive solutions. Academic and research institutes contribute to the market by conducting studies on the safety, effectiveness, and potential innovations of hormonal implants, which may further drive the development of new products and improve the overall offerings in the market. The growth of this market is strongly influenced by these segments, each catering to distinct but complementary needs within the healthcare landscape.

Global Hormonal Implants Segment Analysis

In this report, the Global Hormonal Implants Market has been segmented by Hormone, Type, Distribution Sector, End User, and Geography.

Global Hormonal Implants Market, Segmentation by Hormone

The Global Hormonal Implants Market has been segmented by Hormone into Levonorgestrel and Etonogestrel.

The global hormonal implants market has been segmented by hormone into two main categories: levonorgestrel and etonogestrel. Levonorgestrel implants are widely used in contraceptive methods and hormone replacement therapy. They work by releasing a synthetic form of the hormone progesterone, which prevents ovulation and thickens cervical mucus, thereby inhibiting sperm from reaching the egg. Levonorgestrel implants are known for their high efficacy, long duration of action, and reversible nature, making them a popular choice among women seeking reliable contraception.

On the other hand, etonogestrel implants are a newer addition to the hormonal implants market. These implants contain etonogestrel, a synthetic progestin hormone similar to levonorgestrel. Etonogestrel implants are primarily used for contraceptive purposes and are inserted subdermally into the upper arm, where they gradually release the hormone over a period of several years. These implants offer a highly effective and discreet contraceptive option, with the advantage of requiring minimal user intervention once inserted. As a result, etonogestrel implants are gaining traction among women seeking long-term contraception with low maintenance.

The segmentation of the global hormonal implants market by hormone reflects the diverse needs and preferences of healthcare providers and patients. While levonorgestrel implants have been widely used and studied for decades, etonogestrel implants represent a newer innovation in hormonal contraception. Both types of implants offer significant advantages in terms of efficacy, convenience, and duration of action, contributing to their growing adoption worldwide. As research and development efforts continue to improve the safety and efficacy of hormonal implants, these devices are expected to play a vital role in addressing the global demand for long-acting contraceptive methods and hormone replacement therapy.

Global Hormonal Implants Market, Segmentation by Type

The Global Hormonal Implants Market has been segmented by Type into One Rod Device and Two Rod Device.

The global hormonal implants market has been segmented by type into one rod device and two rod device, offering patients and healthcare providers options tailored to individual needs and preferences. One rod devices typically contain a single hormonal implant inserted subdermally, providing a sustained release of hormones over an extended period. These implants are favored for their convenience, effectiveness, and low-maintenance nature, making them an attractive option for individuals seeking long-term contraception or hormone replacement therapy.

On the other hand, two rod devices feature dual implants placed subdermally, offering a higher dose or a combination of hormones compared to their single-rod counterparts. This segment of the market caters to patients requiring a more potent hormonal regimen or those with specific hormonal imbalances that may benefit from a dual-implant approach. The availability of both one rod and two rod devices provides flexibility for healthcare providers to tailor treatment plans according to the unique needs and medical histories of their patients.

The segmentation of the global hormonal implants market into one rod and two rod devices reflects the diversity of options available to address hormonal disorders, contraception, and hormone replacement therapy. Both types of devices offer distinct advantages and are supported by ongoing advancements in implant technology, ensuring efficacy, safety, and patient satisfaction. As demand for long-acting contraceptive methods continues to rise and awareness of hormonal disorders increases, the market for both one rod and two rod hormonal implants is expected to witness sustained growth, driven by the need for effective and convenient solutions for hormonal management.

Global Hormonal Implants Market, Segmentation by Distribution Sector

The Global Hormonal Implants Market has been segmented by Distribution Sector into Public Sector and Private Sector.

In the public sector, hormonal implants are primarily distributed through government health programs and public healthcare facilities. This sector focuses on making contraceptive solutions, including hormonal implants, accessible and affordable, particularly in low- and middle-income countries. Public health organizations often provide subsidized or free access to these implants, aiming to improve family planning and reproductive health. The public sector's role is crucial in ensuring widespread adoption, especially in areas where awareness and healthcare infrastructure may be limited.

In contrast, the private sector is characterized by distribution through private healthcare providers, pharmacies, and specialized clinics. This sector typically caters to individuals who are willing to pay for more personalized services and quicker access to hormonal implants. The private sector often offers a broader range of options, such as specialized consultations, customized treatments, and more immediate availability, which can appeal to women seeking more discretion or faster service. While the cost of implants in the private sector tends to be higher, the convenience and higher level of care provided contribute to its appeal for those who can afford it. Together, both sectors complement each other, with the public sector focusing on accessibility and the private sector offering flexibility and convenience for those seeking immediate or customized care.

Global Hormonal Implants Market, Segmentation by End User

The Global Hormonal Implants Market has been segmented by End User into Hospitals & Clinics and Academic & Research Institutes.

Hospitals and clinics are the primary settings where hormonal implants are administered, serving as the main point of access for patients seeking long-term contraceptive solutions. These healthcare facilities provide the necessary infrastructure, trained professionals, and support for the implantation process. Hospitals and clinics cater to a broad range of patients, from those seeking family planning services to those looking for more specialized reproductive health treatments. Their role is vital in ensuring that hormonal implants are available, accessible, and effectively implemented, with follow-up care provided to monitor patient outcomes.

Academic and research institutes, on the other hand, contribute to the growth of the hormonal implants market through scientific research, clinical trials, and innovation. These institutions conduct studies to evaluate the safety, efficacy, and potential improvements in hormonal implant technology. Their findings not only drive the development of new products but also inform healthcare providers and policy-makers about the best practices in hormonal implant usage. Research institutes often collaborate with healthcare providers to improve implant formulations, delivery systems, and patient experiences. Through their research and data collection, academic and research institutes help refine the products available in the market and ensure that hormonal implants meet evolving healthcare needs.

Global Hormonal Implants Market, Segmentation by Geography

In this report, the Global Hormonal Implants Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Hormonal Implants Market Share (%), by Geographical Region, 2024

In the global hormonal implants market, geographical regions play a significant role in shaping market dynamics and market share distribution. North America, comprising the United States and Canada, holds a substantial share due to factors such as high healthcare expenditure, favorable reimbursement policies, and increasing awareness about long-acting contraceptive methods and hormone replacement therapy. Additionally, robust research and development activities and the presence of key market players contribute to North America's prominent position in the global hormonal implants market.

Europe is another significant region in the global hormonal implants market, accounting for a considerable market share. Countries within Europe, such as Germany, France, and the United Kingdom, have well-established healthcare infrastructure and policies supporting contraceptive access, driving the adoption of hormonal implants. Moreover, increasing efforts by government and non-governmental organizations to promote family planning and reproductive health contribute to the growth of hormonal implants in the region. However, market growth may vary across European countries due to differences in healthcare policies and cultural attitudes towards contraception and hormone therapy.

Asia-Pacific represents a region with immense growth potential in the global hormonal implants market. Countries like China, India, and Japan are witnessing rapid urbanization, increasing disposable income, and improving healthcare infrastructure, which are driving the demand for hormonal implants. Furthermore, rising awareness about family planning, increasing focus on women's health, and expanding access to contraceptive services contribute to market growth in the region. However, market penetration may face challenges in some parts of Asia-Pacific due to cultural and religious factors, as well as variations in regulatory frameworks across countries. Nonetheless, strategic investments by key market players and initiatives to address unmet healthcare needs present significant growth opportunities in the Asia-Pacific region for hormonal implants.

This report provides an in depth analysis of various factors that impact the dynamics of Global Hormonal Implants Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Key players in Global Hormonal Implants Market include:

• Merck & Co., Inc.
• Bayer AG
• Allergan plc (now part of AbbVie Inc.)
• Pfizer Inc.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V. (now part of Viatris Inc.)
• BioSante Pharmaceuticals, Inc.
• Radius Health, Inc.
• Agile Therapeutics, Inc.

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis